Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 6 (2009), Issue 5 (May)

1. Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.
   Cancer Chemother Pharmacol, 64(1): 171-5. [Abstract] [Full-text]
2. Proteomic and immunologic analyses of brain tumor exosomes.
   FASEB J, 23(5): 1541-57. [Abstract] [Full-text]
3. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
   Lancet Oncol, 10(5): 467-74. [Abstract] [Full-text]
4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
   Lancet Oncol, 10(5): 459-66. [Abstract] [Full-text]
5. Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma.
   Cancer, 115(10): 2188-98. [Abstract] [Full-text]
6. The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells.
   Int J Cancer, 125(1): 235-43. [Abstract] [Full-text]
7. Limits of CD133 as a marker of glioma self-renewing cells.
   Int J Cancer, 125(1): 244-8. [Abstract] [Full-text]
8. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
   Int J Cancer, 125(1): 15-22. [Abstract] [Full-text]
9. Imaging of human brain tumor tissue by near-infrared laser coherence tomography.
   Acta Neurochir (Wien), 151(5): 507-17; discussion 517. [Abstract] [Full-text]
10. Re-operation is a safe and effective therapeutic strategy in recurrent WHO grade II gliomas within eloquent areas.
    Acta Neurochir (Wien), 151(5): 427-36; discussion 436. [Abstract] [Full-text]
11. Occipital ganglio-neuroblastoma in an adult.
    Acta Neurochir (Wien), 151(5): 495-6. [Abstract] [Full-text]
12. Cabergoline resistance in pediatric prolactinomas.
    J Pediatr Hematol Oncol, 31(5): 377-9. [Abstract] [Full-text]
13. Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development.
    Blood, 113(19): 4677-80. [Abstract] [Full-text]
14. Immuno-laser capture microdissection of frozen prolactioma sections to prepare proteomic samples.
    Colloids Surf B Biointerfaces, 71(2): 187-93. [Abstract] [Full-text]
15. Congenital glioblastoma.
    Pediatr Blood Cancer, 53(1): 124-6. [Abstract] [Full-text]
16. Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma.
    Pediatr Blood Cancer, 53(1): 37-41. [Abstract] [Full-text]
17. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.
    Glia, 57(9): 989-99. [Abstract] [Full-text]
18. A rosette-forming glioneuronal tumor of the spinal cord: the first case of a rosette-forming glioneuronal tumor originating from the spinal cord.
    Hum Pathol, 40(6): 898-901. [Abstract] [Full-text]
19. In vivo micro-CT imaging of rat brain glioma: a comparison with 3T MRI and histology.
    Neurosci Lett, 458(1): 28-31. [Abstract] [Full-text]
20. Treatment of Rathke's cleft cysts: experience at a single centre.
    J Clin Neurosci, 16(7): 900-3. [Abstract] [Full-text]
21. Use of spontaneous ventilation to monitor the effects of posterior fossa surgery in the sitting position.
    J Clin Neurosci, 16(7): 968-9. [Abstract] [Full-text]
22. Different responses of cavernous malformations and arteriovenous malformations to radiosurgery.
    J Clin Neurosci, 16(7): 945-9. [Abstract] [Full-text]
23. Oncogenic role of microRNAs in brain tumors.
    Acta Neuropathol, 117(6): 599-611. [Abstract] [Full-text]
24. Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome.
    Acta Neuropathol, 117(6): 653-6. [Abstract] [Full-text]
25. Expression of EAAT-1 distinguishes choroid plexus tumors from normal and reactive choroid plexus epithelium.
    Acta Neuropathol, 117(6): 667-75. [Abstract] [Full-text]
26. Histopathologic predictors of pilocytic astrocytoma event-free survival.
    Acta Neuropathol, 117(6): 657-65. [Abstract] [Full-text]
27. Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice.
    J Clin Oncol, 27(15): 2542-52. [Abstract] [Full-text]
28. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
    Acta Radiol, 50(5): 521-30. [Abstract] [Full-text]
29. Ursolic acid inhibits IL-1beta or TNF-alpha-induced C6 glioma invasion through suppressing the association ZIP/p62 with PKC-zeta and downregulating the MMP-9 expression.
    Mol Carcinog, 48(6): 517-31. [Abstract] [Full-text]
30. Expression of p18(INK4C) is down-regulated in human pituitary adenomas.
    Endocr Pathol, 20(2): 114-21. [Abstract] [Full-text]
31. Molecular advances of brain tumors in radiation oncology.
    Semin Radiat Oncol, 19(3): 171-8. [Abstract] [Full-text]
32. Therapeutic targets in malignant glioblastoma microenvironment.
    Semin Radiat Oncol, 19(3): 163-70. [Abstract] [Full-text]
33. Functional and metabolic magnetic resonance imaging and positron emission tomography for tumor volume definition in high-grade gliomas.
    Semin Radiat Oncol, 19(3): 155-62. [Abstract] [Full-text]
34. Chemotherapy for malignant gliomas.
    Semin Radiat Oncol, 19(3): 150-4. [Abstract] [Full-text]
35. Beyond grade: molecular pathology of malignant gliomas.
    Semin Radiat Oncol, 19(3): 142-9. [Abstract] [Full-text]
36. Demethoxycurcumin induces Bcl-2 mediated G2/M arrest and apoptosis in human glioma U87 cells.
    Biochem Biophys Res Commun, 384(4): 420-5. [Abstract] [Full-text]
37. The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine.
    J Exp Clin Cancer Res, 28: 60. [Abstract] [Full-text]
38. Cerebral astroblastoma: analysis of six cases and critical review of treatment options.
    J Neurooncol, 93(3): 369-78. [Abstract] [Full-text]
39. Multiple intracranial melanoma metastases: case report and review of the literature.
    J Neurooncol, 93(3): 413-20. [Abstract] [Full-text]
40. Imaging biological activity of a glioblastoma treated with an individual patient-tailored, experimental therapy regimen.
    J Neurooncol, 93(3): 425-30. [Abstract] [Full-text]
41. Coincidence of central neurocytoma and multiple glioblastomas: a rare case report.
    J Neurooncol, 93(3): 431-5. [Abstract] [Full-text]
42. Epilepsy in glioblastoma multiforme: correlation with glutamine synthetase levels.
    J Neurooncol, 93(3): 319-24. [Abstract] [Full-text]
43. Epilepsy in cerebral glioma: timing of appearance and histological correlations.
    J Neurooncol, 93(3): 395-400. [Abstract] [Full-text]
44. Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients.
    J Neurooncol, 93(3): 379-84. [Abstract] [Full-text]
45. Contribution of the daily melatonin profile to diagnosis of tumors of the pineal region.
    J Neurooncol, 93(3): 387-94. [Abstract] [Full-text]
46. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.
    J Neurooncol, 93(3): 349-54. [Abstract] [Full-text]
47. miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors.
    J Neurooncol, 93(3): 325-32. [Abstract] [Full-text]
48. Induced interleukin-8 expression in gliomas by tumor-associated macrophages.
    J Neurooncol, 93(3): 289-301. [Abstract] [Full-text]
49. Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.
    J Neurooncol, 93(3): 303-18. [Abstract] [Full-text]
50. High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas.
    J Neurooncol, 93(3): 343-8. [Abstract] [Full-text]
51. Primary CNS lymphoma presenting as fever of unknown origin.
    J Neurooncol, 93(3): 401-4. [Abstract] [Full-text]
52. Germ cell tumors of the brainstem: report on two cases with pulmonary complications and a review of the literature.
    J Neurooncol, 93(3): 405-8. [Abstract] [Full-text]
53. Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report.
    J Neurooncol, 93(3): 409-12. [Abstract] [Full-text]
54. Gamma knife radiosurgery for metastatic brain tumors from thyroid cancer.
    J Neurooncol, 93(3): 355-9. [Abstract] [Full-text]
55. Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.
    J Clin Oncol, 27(16): 2592-7. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.